Back to top

Zai Lab Advances Early Stage ZL-1310 Lung Cancer Trial, Keeping Investor Focus on Pipeline Progress

Zai Lab Ltd ($ZLAB) announced an update on their ongoing clinical study. Zai Lab Ltd. is running an open label, multicenter study called “An Open-l...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Zai Lab Limited Unsponsored ADR (ZLAB)